ECM
AVNS

ETrade Capital Management’s Avanos Medical AVNS Stock Holding History

ETrade Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,420
Closed -$645K – 739
2018
Q3 		$645K Sell
9,420
-368
-4% -$23.7K 0.02% 485
2018
Q2 		$560K Buy
9,788
+502
+5% +$26.5K 0.02% 503
2018
Q1 		$428K Sell
9,286
-1,046
-10% -$49.7K 0.01% 550
2017
Q4 		$477K Buy
10,332
+315
+3% +$14.5K 0.02% 515
2017
Q3 		$451K Buy
10,017
+346
+4% +$14.8K 0.02% 497
2017
Q2 		$380K Buy
9,671
+390
+4% +$14.7K 0.01% 517
2017
Q1 		$354K Buy
9,281
+2,383
+35% +$92.9K 0.01% 492
2016
Q4 		$255K Buy
+6,898
New +$247K 0.01% 513

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ETrade Capital Management's AVNS Position: Q4 2018 in Review

ETrade Capital Management sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 9,420 shares — an estimated $645K sold.

ETrade Capital Management first reported a position in AVNS in Q4 2016 and held it in 8 quarters. The position peaked at $645K in Q3 2018. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • ETrade Capital Management reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • ETrade Capital Management sold 9,420 Avanos Medical shares in Q4 2018, an estimated $645K.
  • ETrade Capital Management first reported a position in Avanos Medical in Q4 2016 and held it in 8 quarters.
  • ETrade Capital Management's Avanos Medical position peaked at $645K in Q3 2018.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on ETrade Capital Management's 13F filing for Q4 2018, filed 8 Feb 2019.